Skip to content

PNEUMO-ALLERGY: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

PNEUMO-ALLERGY

BE 0833.129.436
NACE 86.220, Specialist medical practice
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€180,039
2024 · €152,407+€27,632
Equity
€709,648
2024 · €610,803+€98,845
Cash
€454,294
2024 · €402,865+€51,429
Balance sheet total
€817,217
2024 · €729,126+€88,091

Largest movements

2024 to 2025
Assets
  • Cash +€51,429

    up €51,429 (+12.8%), from €402,865 to €454,294

    mainly Net result for the year (+€180,039) and Depreciation (+€781)

  • Current investments +€28,574

    up €28,574 (+11.3%), from €253,126 to €281,699

Equity and liabilities
  • Reserves +€98,845

    up €98,845 (+17.8%), from €554,243 to €653,088

Income statement
  • Gross operating margin +€43,066

    up €43,066 (+20.5%), from €209,877 to €252,943

  • Taxes +€12,837

    up €12,837 (+19.7%), from €65,103 to €77,941

  • Financial income -€5,071

    down €5,071 (-40.6%), from €12,492 to €7,421

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €152,407
Gross operating margin +€43,066
Depreciation +€2,458
Other operating charges -€57
Financial income -€5,071
Financial charges +€74
Taxes -€12,837
Result 2025 €180,039
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€162,915
Investment -€30,292
Financing -€81,194
Cash 2024 €402,865
Net result for the year +€180,039
Depreciation +€781
Receivables within one year -€5,233
Deferred charges and accrued income -€1,918
Trade debts -€1,537
Tax, wage and social debts -€6,588
Other debts -€3,132
Accrued charges and deferred income +€503
Investment in fixed assets (net) -€1,719
Current investments -€28,574
Contributions, distributions and other -€81,194
Cash 2025 €454,294
brings cash intakes cash out
Every line side by side 40 lines
Line Code 2024 2025 Change %
Total assets 20/58 €729,126 €817,217 +€88,091 +12.1%
Fixed assets 21/28 €774 €1,712 +€938 +121%
Tangible fixed assets 22/27 €774 €712 -€62 -8.0%
Plant, machinery and equipment 23 €318 - -€318
Furniture and vehicles 24 €456 €712 +€256 +56.2%
Financial fixed assets 28 - €1,000 +€1,000
Current assets 29/58 €728,352 €815,505 +€87,153 +12.0%
Amounts receivable within one year 40/41 €69,013 €74,245 +€5,233 +7.6%
Trade receivables 40 €1,797 €2,109 +€312 +17.4%
Other amounts receivable 41 €67,216 €72,137 +€4,921 +7.3%
Current investments 50/53 €253,126 €281,699 +€28,574 +11.3%
Cash at bank and in hand 54/58 €402,865 €454,294 +€51,429 +12.8%
Deferred charges and accrued income 490/1 €3,348 €5,266 +€1,918 +57.3%
Total equity and liabilities 10/49 €729,126 €817,217 +€88,091 +12.1%
Equity 10/15 €610,803 €709,648 +€98,845 +16.2%
Contributions 10/11 €12,400 €12,400 = 0.0%
Reserves 13 €554,243 €653,088 +€98,845 +17.8%
Distributable reserves 133 €554,243 €653,088 +€98,845 +17.8%
Profit (loss) carried forward 14 €44,159 €44,159 = 0.0%
Amounts payable 17/49 €118,323 €107,569 -€10,754 -9.1%
Amounts payable within one year 42/48 €116,173 €104,916 -€11,257 -9.7%
Trade debts 44 €5,016 €3,479 -€1,537 -30.6%
Suppliers 440/4 €5,016 €3,479 -€1,537 -30.6%
Taxes, remuneration and social security 45 €24,962 €18,374 -€6,588 -26.4%
Taxes 450/3 €20,642 €13,914 -€6,728 -32.6%
Remuneration and social security 454/9 €4,320 €4,460 +€140 +3.2%
Other amounts payable 47/48 €86,195 €83,064 -€3,132 -3.6%
Accrued charges and deferred income 492/3 €2,150 €2,653 +€503 +23.4%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €3,238 €781 -€2,458 -75.9%
Other operating charges 640/8 €607 €664 +€57 +9.4%
Gross operating margin 9900 €209,877 €252,943 +€43,066 +20.5%
Operating profit (loss) 9901 €206,031 €251,498 +€45,467 +22.1%
Financial income 75/76B €12,492 €7,421 -€5,071 -40.6%
Recurring financial income 75 €12,492 €7,421 -€5,071 -40.6%
Financial charges 65/66B €1,013 €939 -€74 -7.3%
Recurring financial charges 65 €1,013 €939 -€74 -7.3%
Profit (loss) for the period before taxes 9903 €217,511 €257,980 +€40,469 +18.6%
Income taxes 67/77 €65,103 €77,941 +€12,837 +19.7%
Profit (loss) for the period 9904 €152,407 €180,039 +€27,632 +18.1%
Profit (loss) for the period to be appropriated 9905 €152,407 €180,039 +€27,632 +18.1%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 1 November 2026 via checked.be.